Quantcast

Alonso Krangle LLP Continues to File Fosamax Side Effect Lawsuits on Behalf of Women who Sustained Femur Fractures, Allegedly Due to Long-Term Use of Fosamax

September 13, 2012

Four New Fosamax Lawsuits Filed in New Jersey Superior Court Allege that Long-Term Use of Fosamax Caused Plaintiffs to Sustain Severe and Permanent Injuries, Including Femur Fractures.

Melville, NY (PRWEB) September 12, 2012

Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, has filed four new Fosamax side effect lawsuits alleging long-term use of Fosamax caused women to sustain severe and permanent injuries, including femur fractures. All of the lawsuits were filed in the Superior Court of New Jersey, Atlantic County Division, were all New Jersey Fosamax lawsuit have been centralized as a Mass Tort. The four Fosamax lawsuits filed by Alonso Krangle LLP name Sharp & Dohme Corp. f/k/a Merck & Company, Inc. and Teva Pharmaceuticals as Defendants. (Docket Numbers: L-5686-12; L-5717-12; L-5716-12; and L-5715-12)

About Alonso Krangle LLP

Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City and New Jersey.

Alonso Krangle LLP is currently offering free Fosamax lawsuit evaluations to anyone who experienced a femur fracture while using this drug. To discuss a potential lawsuit claim with one of the experienced and compassionate Fosamax side effects lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

All of the Plaintiffs being represented by Alonso Krangle LLP claim that they used Fosamax as prescribed, and in a foreseeable manner prior to sustaining their femur fractures. The lawsuits allege that long-term use of Fosamax caused the Plaintiffs to suffer permanent injuries and emotional distress, along with economic losses due to medical expenses, and living-related expenses resulting from the new life-style necessitated by their injuries. They further allege that the Defendants knew of the significant risk of severely suppressed bone turnover, brittle bones, and multiple stress fractures associated with long-term use of Fosamax, but did not sufficiently warn consumers, the Plaintiffs, their doctors or the medical community of those risks.

Fosamax and other bisphosphonates are used treat bone disorders, such as osteoporosis and Paget´s disease. In October 2010, the U.S. Food & Drug Administration (FDA) directed the makers of Fosamax and other bisphosphonates used to treat osteoporosis to add information to the “Warnings and Precautions” section of the drugs´ labels describing the risk of atypical thigh fractures associated with long-term use of bisphosphonates. [fda.gov/drugs/drugsafety/ucm229009.htm]

Since the FDA safety notice was issued, additional research has cast doubt on the benefits of using Fosamax and other bisphosphonates over a long period of time. In May, an analysis published in the New England Journal of Medicine (NEJM) by researchers with the FDA found little benefit from the long-term use of bisphosphonates (longer than five years) because of their potential association with serious side effects, including atypical thigh fractures, Osteonecrosis of the Jaw (ONJ or Dead Jaw Syndrome), and esophageal cancer. [nejm.org/doi/full/10.1056/NEJMp1202619]

Another study published in May in the Archives of Internal Medicine reported that the association between bisphosphonate treatment and the occurrence of atypical femur fractures is highly likely, and that the duration of bisphosphonate treatment significantly correlates with the rising risk. [archinte.jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2012.1827]

Alonso Krangle LLP continues to offer free lawsuit evaluations to any Fosamax user who suffered a femur fracture or other side effect that could be associated with long-term use of this drug. To discuss a potential claim with one of the experienced and compassionate Fosamax femur fracture lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:

Alonso Krangle LLP

445 Broad Hollow Road

Suite 205

Melville, New York 11747

Toll-FREE 1-800-403-6191

Tel: 516-350-5555

Fax: 516-350-5554

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9836300.htm


Source: prweb



comments powered by Disqus